Status:
WITHDRAWN
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
Lead Sponsor:
Global BioClinical
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
The study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing. This study will ultimately provide cancer researchers wi...
Detailed Description
This study will enroll subjects diagnosed with various cancers and who are scheduled to undergo surgical treatment. Prior to scheduled surgery, subjects will be asked to donate a 10-20 ml blood sample...
Eligibility Criteria
Inclusion
- Any adult age
- Any sex
- Able to provide consent for surplus tissue and/or blood donation
- Diagnosed with one of the cancer indications listed below:
- Scheduled to undergo surgical resection of tumor (exception for hematological cancers)
- Have not yet received treatment for cancer
Exclusion
- Not diagnosed with required cancer indication
- Not scheduled to undergo surgical resection of the tumor
- Have already received cancer treatment (such as chemotherapy, radiation, surgery) for the current cancer or a previously diagnosed cancer
- Not able to donate an adequate volume of blood to meet minimum requirements
- CANCER INDICATIONS:
- Bladder Cancer - Urothelial carcinoma - nonpapillary
- Bladder Cancer - Urothelial carcinoma - papillary
- Brain Cancer - Astrocytoma
- Brain Cancer - Glioblastoma
- Brain Cancer - Medulloblastoma
- Breast Cancer - Ductal Carcinoma
- Breast Cancer - Lobular Carcinoma
- Cervical Cancer - Squamous Cell Carcinoma
- Colorectal Cancer - Adenocarcinoma
- Esophageal Cancer - Adenocarcinoma
- Gastric Cancer
- Head and Neck Cancer - Squamous Cell Carcinoma
- Hematologic Cancer - Acute Lymphocytic Leukemia (ALL)
- Hematologic Cancer - Acute Myeloid Leukemia (AML)
- Hematologic Cancer - Chronic Lymphocytic Leukemia (CLL)
- Hematologic Cancer - Diffuse Large B-cell Lymphoma
- Hematologic Cancer - Multiple Myeloma (MM)
- Hematologic Cancer - Non-Hodgkins Lymphoma (NHL)
- Kidney Cancer - Papillary Carcinoma
- Kidney Cancer - Renal cell Carcinoma
- Liver Cancer - Hepatocellular Carcinoma
- Lung Cancer - Adenocarcinoma
- Lung Cancer - Squamous Cell Cancer
- Melanoma
- Pancreatic Cancer - Ductal Adenocarcinoma
- Prostate Cancer - Adenocarcinoma
- Sarcomas
- Thyroid Cancer - Follicular Carcinoma
- Thyroid Cancer - Papillary Carcinoma
- Uterine Cancer - Endometrial Carcinoma
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 27 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01792882
Start Date
February 1 2013
End Date
February 27 2023
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GBC
Seattle, Washington, United States, 98104